These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 11140685)

  • 21. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
    Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J
    Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease.
    Grossi C; Francese S; Casini A; Rosi MC; Luccarini I; Fiorentini A; Gabbiani C; Messori L; Moneti G; Casamenti F
    J Alzheimers Dis; 2009; 17(2):423-40. PubMed ID: 19363260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of intracellular A beta in Alzheimer's disease].
    Tabira T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):175-80. PubMed ID: 12451689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.
    Liu L; Ikonen S; Heikkinen T; Tapiola T; van Groen T; Tanila H
    Exp Neurol; 2002 Feb; 173(2):196-204. PubMed ID: 11822883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vaccination therapy for Alzheimer's disease].
    Tabira T
    Brain Nerve; 2007 Apr; 59(4):375-82. PubMed ID: 17447524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
    Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
    J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.
    DeMattos RB; Bales KR; Cummins DJ; Paul SM; Holtzman DM
    Science; 2002 Mar; 295(5563):2264-7. PubMed ID: 11910111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease.
    Lee JY; Kweon HS; Cho E; Lee JY; Byun HR; Kim DH; Kim YH; Han PL; Koh JY
    Neurosci Lett; 2007 Aug; 423(1):82-7. PubMed ID: 17662525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
    Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
    Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
    Donovan MH; Yazdani U; Norris RD; Games D; German DC; Eisch AJ
    J Comp Neurol; 2006 Mar; 495(1):70-83. PubMed ID: 16432899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Trial to produce animal model of Alzheimer's disease by continuous infusion of beta-amyloid protein into the rat cerebral ventricle].
    Nabeshima T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Oct; 15(5):411-8. PubMed ID: 8564734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's congress. Further progress on a beta-amyloid vaccine.
    Helmuth L
    Science; 2000 Jul; 289(5478):375. PubMed ID: 10939941
    [No Abstract]   [Full Text] [Related]  

  • 35. Alzheimer's disease. Antibody clears senile plaques.
    St George-Hyslop PH; Westaway DA
    Nature; 1999 Jul; 400(6740):116-7. PubMed ID: 10408433
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental techniques for developing new drugs acting on dementia (10)--Alzheimer's disease animal model induced by beta-amyloid protein].
    Nitta A; Nabeshima T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):85-90. PubMed ID: 8905795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccines for Alzheimer's disease: how close are we?
    Janus C
    CNS Drugs; 2003; 17(7):457-74. PubMed ID: 12751917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging Alzheimer's amyloid.
    Selkoe DJ
    Nat Biotechnol; 2000 Aug; 18(8):823-4. PubMed ID: 10932146
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunologic treatment of Alzheimer's disease.
    Blass JP
    N Engl J Med; 1999 Nov; 341(22):1694-5. PubMed ID: 10572162
    [No Abstract]   [Full Text] [Related]  

  • 40. Anaesthetics and postoperative cognitive dysfunction: a pathological mechanism mimicking Alzheimer's disease.
    Fodale V; Santamaria LB; Schifilliti D; Mandal PK
    Anaesthesia; 2010 Apr; 65(4):388-95. PubMed ID: 20136805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.